top of page

Search Results

Results found for "neuroimmune signaling"

  • GPCR Intelligence Hub — Every Resource in GPCR Science, Searchable | Dr. GPCR Ecosystem

    the assays and frameworks for measuring GPCR internalization — from beta-arrestin gating to endosomal signaling via actin cytoskeleton remodeling. 🔒 Read Publication April 7, 2026 GPCR Internalization: When the Signal Moves Inside the Cell GPCR internalization does not end signaling — it redirects it. Yamina Berchiche Read the Article April 6, 2026 The Expanding Landscape of the Glucagon Signaling Network : mechanisms and outcomes Review of glucagon signaling mechanisms beyond glycemic control, covering effects

  • Dr. Benjamin Myers | Dr. GPCR Ecosystem

    His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors More recently, Ben’s lab has begun studying GPCR signaling pathways that operate within the primary cilium Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford

  • Dr. Paul J. Gasser | Dr. GPCR Ecosystem

    Gasser " I received my BS and MS in Zoology & Physiology at the University of Wyoming, where I studied signaling Lowry's lab, examined the role of organic cation transporter 3 (OCT3) in the regulation of monoamine signaling Research in my lab is currently focused on understanding the signal transduction pathways activated by

  • Dr. AurĂ©lien Rizk | Dr. GPCR Ecosystem

    InterAx Biotech, where he specializes in the development of a technology platform deciphering cell signaling pathways combined with AI-based approaches to elucidate structure to signaling relationship. Gebhard Schertler, he developed methods for kinetic mathematical analysis of GPCR signaling. Biotech, shared about the company's development of a discovery platform for GPCRs and their focus on signaling about the intricacies of cell signaling and chemokine receptors.

  • Dr. Brian Arey | Dr. GPCR Ecosystem

    the first described synthetic agonists and antagonists of the FSHR and has been an early champion of signaling His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

  • Dr. Brian Arey | Dr. GPCR Ecosystem

    the first described synthetic agonists and antagonists of the FSHR and has been an early champion of signaling His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

  • Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem

    NIDDK) - NIH, USA as a postdoctoral fellow and trained on understanding the physiological role of GPCR signaling GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D) by exploring metabolically important signaling Sai Prasad Pydi on the web Molecular Metabolism & Cell Signaling Laboratory Website Twitter.com Research

  • Dr. Stephen Ferguson | Dr. GPCR Ecosystem

    receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors signaling of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling

  • Dr. Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem

    Industrial GPCR Pharmacology Scientific Abstract This conversation traces how GPCR pharmacology, receptor signaling , the identification of receptor activity-modifying proteins (RAMPs), and the realization that CGRP signaling The discovery of RAMPs was only possible because the assay tied receptor signaling to a highly amplified Apart from APOE4 in Alzheimer’s disease, most signals failed to reach robustness with available cohort at GSK, expectations for GPCR target discovery from association studies, and reflections on why many signals

  • FAQ | Dr. GPCR Ecosystem

    live online scientific sessions focused on G protein-coupled receptor (GPCR) biology, pharmacology, signaling entering drug discovery If you work directly with receptor systems, ligand design, efficacy modeling, or signaling These webinars are designed for scientists with foundational knowledge in receptor pharmacology, signaling models • Allosteric modulators (PAMs and NAMs) • Biased agonism • Dose–response modeling • Calcium and signaling

  • Dr. Davide Calebiro | Dr. GPCR Ecosystem

    engineers and computer scientists focusing on the basic mechanisms of G protein-coupled receptor (GPCR) signalling To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule microscopy, which allow them to directly observe signalling events in living cells and tissues with

  • Dr. Stephen Ferguson | Dr. GPCR Ecosystem

    receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors signaling of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling

  • Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem

    I then undertook my first project where I demonstrated that MRAP2 regulates the signaling of multiple Concurrently, I described the mechanisms by which MRAP2 regulates GHSR1a signaling; this project brought Using this novel technique, I showed that MRAP2 biased GHSR1a signaling and shut down its constitutive activity; this work resulted in a first author publication in Science Signaling. to create a scientific session at the American Physiology Summit (APS) 2024 dedicated to GPCR biased signaling

  • Dr. Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem

    If the right ligand could engage G-protein signaling while sparing β-arrestin, pain relief might finally Her lab now studies δ- and μ-opioid receptor signaling, biased agonism, receptor trafficking and recycling Even as the field pushes toward iPSC-derived somatic systems, HEK-cell signaling profiles of μ-opioid Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling , trafficking, and their ability to activate different signaling pathways and signaling bias.

  • GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem

    How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes Why strategic flexibility in exploring non-canonical signaling pathways is critical for GPCR-targeted Researchers refining strategies for high-throughput screening or exploring biased signaling. fellowship at GSK, where he entered the GPCR field and became proficient in aptamer selection and cell signaling

  • Dr. Randy Hall | Dr. GPCR Ecosystem

    the past two decades, his lab has published numerous groundbreaking findings shedding light on the signaling Most recently, his lab has made a number of seminal contributions to understanding the signaling, regulation has a special interest in studying disease-associated mutations to human GPCRs that perturb receptor signaling

  • Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem

    Beaulieu has pioneered work establishing a role for Beta-arrestin signaling in the brain in vivo and has demonstrated that mood stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target signaling is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling

  • Julia Gardner | Dr. GPCR Ecosystem

    In the Rajagopal Lab, Julia studies the mechanisms of 'biased signaling' at GPCRs, with a specific focus translocate to endosomes, and that the subcellular localization of the GRKs affects a GPCR's biased signaling

  • Dr. Elva Zhao | Dr. GPCR Ecosystem

    she obtained her Ph.D. at the University of Western Ontario, working on the regulation of G proteins signaling Her current research focuses on class B GPCRs and understanding how GPCR signaling and function is mediated

  • Dr. Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem

    spanned chemokine receptor conformational dynamics at the Université de Montréal, CXCR3 splice-variant signaling Tom Sakmar's lab, where she characterized the signaling diversity of three alternative splice variants Splice variants aren't just structural — they signal differently. question from Tom Sakmar, demonstrated that variants encoded by the same gene can recruit different signaling The implication: transcript-level diversity is itself a signaling mechanism, not a cloning artifact to

  • Dr. GPCR Board | Dr. GPCR Ecosystem

    research program is to gain a thorough and mechanistic understanding of processes that control cell signaling The precise control of PAR signaling is critical for proper temporal and spatial dynamics of signaling Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and

  • Annabelle Milner | Dr. GPCR Ecosystem

    Annabelle’s Ph.D. work focuses on microbial-derived metabolites that signal through GPCRs expressed in In particular, she is looking at L- and D-lactate-activated HCAR1 signaling.

  • Dr. G. Aditya Kumar | Dr. GPCR Ecosystem

    understanding the role of the membrane microenvironment in the subcellular organization, trafficking, and signaling the interaction of membrane cholesterol with the serotonin-1A receptor and its effects on receptor signaling

  • Dr. Sudha Shenoy | Dr. GPCR Ecosystem

    ubiquitination of the adaptor protein, β-arrestin, is a tag for receptor internalization and formation of signaling Current efforts aim to understand the regulation of GPCR and beta-arrestin signaling in the heart and

  • Dr. Lauren M. Slosky | Dr. GPCR Ecosystem

    These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor signaling , they are exciting tools for linking distinct signaling pathways with their physiological effects and

  • Dr. Michel Bouvier | Dr. GPCR Ecosystem

    Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. He is a world-renowned expert in the field of cell signaling and GPCRs and made seminal contributions In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones

  • Dylan Eiger | Dr. GPCR Ecosystem

    Dylan's graduate research focuses on the mechanisms underlying biased signaling at GPCRs, specifically , the role of differential receptor phosphorylation (phosphorylation barcodes) and subcellular GPCR signaling

  • Dr. Nicholas Holliday | Dr. GPCR Ecosystem

    regulating appetite, metabolism, and the immune system, and the molecular mechanisms underlying the signaling where he is now Associate Professor, establishing a lab focused on G protein-coupled receptor kinetics, signaling

  • Dr. J. Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem

    Silvio Gutkind, who has spent more than three decades pushing GPCRs as oncogenic signaling systems, the continued at the NIH across neurobiology and oncogenes, and grew into a multi-decade program on GPCR signaling GαS, Gα13) GαQ-driven uveal melanoma and the limits of the canonical PLC pathway Non-canonical GαQ signaling Non-canonical signaling opened a new drug target. In this episode, Silvio discusses G protein signaling in the context of cancer, immunotherapies, and

  • Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem

    she identified novel core cellular machinery critical for G protein-coupled receptor trafficking and signaling fundamental cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling Caroline continued to undertake postdoctoral research in Oxford, investigating the signalling and trafficking

bottom of page